Arcellx - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeArcellx
Arcellx logo

Arcellx

0 followers

ACLX

Performance

About Arcellx

Arcellx is a biotechnology company focused on developing innovative cell therapies for cancer and autoimmune diseases. The company emphasizes reimagining cell therapy and advancing how cancer is treated through engineered cellular approaches. Headquartered with operations described globally, Arcellx positions itself in oncology and immunology with a pipeline aimed at translating scientific breakthroughs into new treatments. The site highlights a mission to pursue a cure for cancer and to push the boundaries of cellular medicine.

Recent News

Recent Deals

Key Team Members

Maryam Abdul-Kareem, JD, MS

General Counsel and Chief Legal Officer

Kate Aiken

Chief People Officer

Doug Alleavitch

Vice President, Quality

Brad Gliner

Vice President, Clinical Research and Regulatory Affairs

Rami Elghandour

Chairman and Chief Executive Officer

Key Facts

HQ Location

Rockville, United States

Founded

2014

Employees

51 - 200

Status

Public

Website

https://arcellx.com